MLKL and hematoma: Admission serum MLKL levels were independently correlated with National Institutes of Health Stroke Scale (NIHSS) scores (beta, 0.133; 95% confidence interval (CI), 0.088–0.178; p = 0.011), hematoma volume (beta, 0.051; 95%CI, 0.037–0.064; p = 0.001), and 6‐month mRS scores (beta, 0.707; 95%CI, 0.487–0.927; p = 0.023), as well as independently predicted END (odds ratio, 1.902; 95%CI, 1.229–2.945; p = 0.014) and poor prognosis (odds ratio, 2.286; 95%CI, 1.324–3.946; p = 0.038).